ArticleJournal of Korean medical science2024

Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study.

Yeonhu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.